Shocking sexual allergies that make a 29-year-old woman infertile

A young Lithuanian woman is working to conceive with her partner — a rare but shocking allergy crime, according to a new case report in the Journal of Medicine.

For the 29-year-old, four years of natural attempts and two rounds of IVF proved invalid, leaving her doctor in trouble.

Because of her sensitivity to mold, cat fur and dust, the woman suspects Her allergies may be a contributing factor.

The following Blood tests show that her eosinophils are high, a type of white blood cell that defends the body against allergens.

In addition to established allergies, skin tests have also shown sensitivity to mites, pollen, insects and dogs.

The test also pointed to a high sensitivity to proteins, found in dog dander and urine, which is related to potential sensitivity to human semen.

The woman shared with her allergic molecules that she often experiences nasal congestion and sneezing after having sex with her partner. Using samples from her partner’s semen, the doctor confirmed that she had a semen allergy.

According to the Cleveland Clinic, a semen allergy, also known as semen plasma hypersensitivity reaction (SPH), is a rare reaction to proteins in male sperm fluid.

SPH is considered a type 1 hypersensitivity reaction characterized by a rapid, exaggerated immune response to allergens, placing semen in the same category as peanuts and pet dander.

For those suffering, reactions to the burning of the vulva or vagina, itching, redness and swelling to the hive, shortness of breath, shortness of breath, dizziness, and even allergic reactions.

The main treatment for SPH is condoms, but in this case the woman is determined to conceive with her partner and avoids latex solutions.

SPH does not directly cause infertility, although the conception can be challenging.

Possible parental treatment includes antihistamines, anti-inflammatory drugs and/or treatment with diluted semen plasma desensitization.

If the allergic reaction is severe, some couples turn to using sperm-free in IVF treatment to metastasize allergic triggers.

In Lithuania, desensitization therapy is not available and the patient found that antihistamines were “ineffective” in managing her reactions before sexual behavior.

In a follow-up visit three years later, the woman revealed that she still couldn’t imagine, and to make matters worse, her allergic symptoms had expanded to include eye irritation and a burning sensation in the vulva.

Last year, her case was detailed in the Journal of Medicine.

SPH was initially recorded in 1967 in 1967, when a woman was hospitalized after being “violently allergic” to sexual acts.

Over the next three decades, SPH is assumed to affect less than 100 women worldwide.

However, a 1997 study led by allergic patient Jonathan Bernstein showed that nearly 12% of reported post-paint symptoms can be classified as SPH.

Now, this is believed to affect 40,000 people.

The authors of the latest report say further research is needed to understand the relationship between SPH and pregnancy. They point out that the root causes of infertility are often challenging.

“This situation reminds people that seemingly unrelated allergic conditions (combined together) can lead to reproductive health challenges and guarantee a full assessment,” they wrote.